Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity.
Molecular genetic studies of multiple sclerosis in the portuguese population.
Multiple sclerosis in pregnancy.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Reduced field-of-view DTI segmentation of cervical spine tissue.
Clinical studies on the efficacy and safety of Padma 28, a complex herbal formulation from Tibetan medicine: an overview.
Body composition and physical function in women with multiple sclerosis.
Cannabinoids: Medical implications.
Bone health in patients with multiple sclerosis relapses.
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.
Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases.
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population.
Oxidised LDL lipids, statins and a blood-brain barrier.
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?

Pages